CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AC4. A total of 21 filers reported holding CLOVIS ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $99,000 | 0.0% | 140,000 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $99,000 | -6.6% | 140,000 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $106,000 | +7.1% | 140,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $99,000 | -2.9% | 140,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $102,000 | -1.9% | 140,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $104,000 | -2.8% | 140,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $107,000 | +8.1% | 140,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $99,000 | -1.0% | 140,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $100,000 | +14.9% | 140,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $87,000 | +2.4% | 140,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $85,000 | -5.6% | 140,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $90,000 | -73.4% | 140,000 | -82.3% | 0.00% | -50.0% |
| Q3 2019 | $338,000 | -31.7% | 790,000 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $495,000 | -2.8% | 790,000 | +21.5% | 0.00% | -25.0% |
| Q1 2019 | $509,000 | -27.6% | 650,000 | -35.0% | 0.00% | -33.3% |
| Q4 2018 | $703,000 | -9.4% | 1,000,000 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $776,000 | -16.0% | 1,000,000 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $924,000 | – | 1,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|